In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 2213-63-0, name is 2,3-Dichloroquinoxaline, introducing its new discovery. Product Details of 2213-63-0
The reactions of 3-aryl-4-amino-5-mercapto-s-triazoles (II; R = m-Cl-C6H4-, p-MeO-C6H4-, o-CH3-C6H4-, m-CH3-C6H4-, p-CH3-C6H4- and o-Br-C6H4-) with chloroacetic acid, alpha-haloketones, benzoin, 2,3-dichloroquinoxaline, chloroacetaldehyde diethylacetal and carbon disulphide furnish in one-step, the more interesting heterocyclic systems whose structures have been established as 3-aryl-5H-s-triazolo<3,4-b><1,3,4>thiadiazin-6-(7H)-one (III), 3,6-disubstituted-7H-s-triazolo<3,4-b><1,3,4>thiadiazines (IV), 3-aryl-6,7-diphenyl-5H-s-triazolo<3,4-b><1,3,4>thiadiazines (V), 3-aryl-5H-s-triazolo<3',4':2,3><1,3,4>thiadiazino<5,6-b>quinoxalines (VI), 3-aryl-7H-s-triazolo<3,4-b><1,3,4>thiadiazine hydrochlorides (VII) and 3-aryl-s-triazolo<3,4-b><1,3,4>thiadiazole-6-(5H)-thiones (VIII), respectively, on the basis of elemental analyses and spectral data.The antibacterial and antifungal activities of some of the compounds have also been evaluated.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 2213-63-0, and how the biochemistry of the body works.Product Details of 2213-63-0
Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1455 | ChemSpider